|
Status |
Public on Jun 16, 2015 |
Title |
Targeting PBK/TOPK decreases growth and survival of glioblastoma stem cells in vitro and attenuates tumor growth in vivo |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Gene knockdown of PBK led to decreased proliferation and sphere formation in the GSC cultures. Treatment of cells with different concentrations of HI-TOPK-032 almost completely abolished growth and proliferation and elicited a large increase in apoptosis
|
|
|
Overall design |
Total RNA isolated from GSC cultures featuring PBK gene knock-down (shRNA) was compared to that from non-silencing control GSC cultures (NS-shRNA). Total RNA isolated from GSC cultures treated with PBK-inhibitor was compared to that from untreated GSC cultures.
|
|
|
Contributor(s) |
Stangeland B |
Citation(s) |
26081429 |
|
Submission date |
Jan 03, 2014 |
Last update date |
Aug 13, 2018 |
Contact name |
Biljana Stangeland |
E-mail(s) |
biljana.stangeland@gmail.com
|
Organization name |
Oslo University Hospital
|
Department |
Institute of Surgical Research
|
Lab |
VML
|
Street address |
Sognsvannsveien 20
|
City |
Oslo |
ZIP/Postal code |
0027 |
Country |
Norway |
|
|
Platforms (1) |
GPL10558 |
Illumina HumanHT-12 V4.0 expression beadchip |
|
Samples (36)
|
|
Relations |
BioProject |
PRJNA233313 |